Genedrive (GDR LN)

Analysis

Health Care • United Kingdom

Genedrive is a molecular diagnostics company that develops and commercializes a rapid, versatile, and easy-to-use point-of-need molecular diagnostics platform. This platform is used for the diagnosis of infectious diseases, genotyping, and pathogen detection. Their key products include the Genedrive MT-RNR1 ID Kit for preventing antibiotic-induced hearing loss in neonates and the Genedrive CYP2C19 ID Kit for personalized antiplatelet treatment in stroke patients. The company is headquartered in Manchester, United Kingdom, and was founded in 2000.

Refresh

Exchange Announcement • 12 Oct 2026 13:00

NIHR highlights genedrive's rapid genetic test

Exchange Announcement • 10 Sep 2026 13:00

Welsh hospitals extend routine MT-RNR1 testing

Exchange Announcement • 03 Sep 2026 13:00

ShareSoc Investor Presentation Reminder

Exchange Announcement • 01 Sep 2026 13:00

Director/PDMR Notification

Exchange Announcement • 21 Aug 2026 13:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

NIHR highlights genedrive's rapid genetic test

Welsh hospitals extend routine MT-RNR1 testing

ShareSoc Investor Presentation Reminder

Director/PDMR Notification

Board Appointments